These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29239680)

  • 21. Rabbit ocular reactivity to bacterial endotoxin contained in aqueous solution and ophthalmic viscosurgical devices.
    Buchen SY; Calogero D; Hilmantel G; Eydelman MB
    Ophthalmology; 2012 Jul; 119(7):e4-e10. PubMed ID: 22578450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
    Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
    Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of subconjunctival biodegradable microfilms for sustained drug delivery to the anterior segment in a small animal model.
    Liu YC; Peng Y; Lwin NC; Wong TT; Venkatraman SS; Mehta JS
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2607-15. PubMed ID: 23518771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).
    Cholkar K; Gilger BC; Mitra AK
    Int J Pharm; 2016 Feb; 498(1-2):326-34. PubMed ID: 26706439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selected Aspects of Ocular Toxicity Studies With a Focus on High-Quality Pathology Reports: A Pathology/Toxicology Consultant's Perspective.
    Short B
    Toxicol Pathol; 2021 Apr; 49(3):673-699. PubMed ID: 32815474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The shifting landscape of safety pharmacology in 2015.
    Pugsley MK; Authier S; Stonerook M; Curtis MJ
    J Pharmacol Toxicol Methods; 2015; 75():5-9. PubMed ID: 26055120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of capillary microsampling in GLP toxicology studies.
    Verhaeghe T; Dillen L; Stieltjes H; Zwart L; Feyen B; Diels L; Vroman A; Timmerman P
    Bioanalysis; 2017 Apr; 9(7):531-540. PubMed ID: 28300424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.
    Perez VL; Barsam A; Duffort S; Urbieta M; Barreras H; Lightbourn C; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1765-1772. PubMed ID: 27492793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular design for enhancement of ocular penetration.
    Shirasaki Y
    J Pharm Sci; 2008 Jul; 97(7):2462-96. PubMed ID: 17918725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compact Magnetic Resonance Imaging Systems-Novel Cost-Effective Tools for Preclinical Drug Safety and Efficacy Evaluation.
    Ramot Y; Schiffenbauer YS; Maronpot R; Nyska A
    Toxicol Sci; 2017 May; 157(1):3-7. PubMed ID: 28329801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Feasibility of Spectral-Domain Optical Coherence Tomography Grading of Anterior Chamber Inflammation in a Rabbit Model of Anterior Uveitis.
    Edmond M; Yuan A; Bell BA; Sharma A; DiCicco RM; Tucker L; Bena J; Tao YK; Srivastava SK
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT184-8. PubMed ID: 27409471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational toxicology: Its essential role in reducing drug attrition.
    Naven RT; Louise-May S
    Hum Exp Toxicol; 2015 Dec; 34(12):1304-9. PubMed ID: 26614820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
    Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular toxicology.
    Novack GD
    Curr Opin Ophthalmol; 1995 Dec; 6(6):108-12. PubMed ID: 10172712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.
    Kramer MS; Leventhal JM; Hutchinson TA; Feinstein AR
    JAMA; 1979 Aug; 242(7):623-32. PubMed ID: 449002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction to Special Issue on Ocular Pathology and Drug Development.
    Ramos MF; Schafer KA; Sorden SD
    Toxicol Pathol; 2021 Apr; 49(3):417-418. PubMed ID: 33397210
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.